Tel: +44(0)20 7691 0984 Email: Newsletter Sign Up
  • CEO Mark Duxon interviewed by The Pharma Letter on impact of Brexit on CROs...
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • State-of-the-art premises opening this month at Discovery Park in Kent...
  • Newly published work in Frontiers in Psychiatry demonstrating
  • the effectiveness of a clinically relevant dose of ketamine...
  • Head to 2021 conferences page to see titles of abstracts...

Our Team

Meet the team! This is our senior management and scientific team. They are supported by twenty other members at various sites. We're involved in many different projects in the UK and across the globe, dedicating the right level of experience and expertise to every client project.

Jack Prenderville PhD


Jack has over 10 years of experience in behavioural and molecular neuropharmacology across academia and industry. After completing a PhD at Trinity College, Dublin, Ireland, he spent time as a visiting researcher at the University of Michigan, USA. Following that, Jack returned to Ireland taking up a postdoctoral researcher post at the APC Microbiome Institute, University College, Cork working within an industry-academia partnership. Jack joined Transpharmation in 2014 and currently leads a team of innovative scientists responsible for translational models of psychiatric, neurodegenerative and inflammatory disorders.

jackAs well as an enthusiastic traveller, Jack is an avid sports fan and an ever-improving short distance runner.


Start a Conversation

uk flag+44 (0)20 7691 0984

ireland flag+353 (0)1896 42 60

poland flag+48 515 244 120



Copyright © 2021 Transpharmation Ltd. All Rights Reserved.

Copyright © 2019 Transpharmation Ltd. All Rights Reserved. Website created by Identity Ipswich Web Design